Clinical Trials Update: Nov. 12, 2003
Breast Cancer Depression (Major/Severe) Colorectal Cancer
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
A study to evaluate the safety, tolerability, and effectiveness of an investigational medication for breast cancer metastatic to bone. Female volunteers at least 18 years old who are using an effective form of birth control, have a documented history of breast cancer, have at least one bone metastasis that has not been previously treated by radiation or surgery, and are not anticipated to be treated within the next 24 weeks may be eligible. Research sites located throughout the United States.
A study of an investigational medication for adult outpatients with major depressive disorder (MDD). Volunteers 18 to 75 who have a primary diagnosis of MDD may be eligible. Research sites located throughout the United States.
A study to assess the safety and efficacy of an investigational medication in people with advanced colorectal cancer. Volunteers with a histologic diagnosis of adenocarcinoma of the colon or rectum who have been previously treated with a fluoropyrimidine (5-FU or capecitabine) and either oxaliplatin or irinotecan (given concurrently or as separate regimens) may be eligible. Research sites located throughout the United States.
Copyright 2003 CenterWatch. All rights reserved.